Asset Quality Lead; Director, Oncology

Job Summary

The Asset Quality Lead (AQL) is responsible for driving GCP Quality by maintaining ‘quality’ line‑of‑sight for assigned clinical trial programs/protocols. With this focus, the AQL role brings deep knowledge of GCP quality and risk management principles to asset and study teams. In partnership with the cross functional study team and functional lines in Clinical Development & Operations, the AQL will ensure program and study level quality oversight, drive quality risk management and inspection readiness activities and will be instrumental in ensuring that asset and study level information is appropriately incorporated within the GCP QMS.

The AQL is the point person to the cross functional study team and other relevant stakeholders for quality risk management, quality issues management and general GCP guidance.

• Ensure clinical development plan strategy and asset‑level risks are incorporated into study and asset level risk management and oversight to support GCP Compliance

• Strategically, utilize quality measures/data to monitor asset/study quality and identify potential risks, quality trends, and support state of quality reporting

• Communicate key quality information across study teams and serve as GCP quality expert to study teams

• Monitor submission risk and flag major risks for Category Quality Head review and other key stakeholders for review

• Oversee study‑level quality risk management activities, including driving Study Risk Profile development/maintenance and QTL implementation by ensuring that quality metrics are monitored and that quality deviations are identified and addressed in a timely and appropriate manner

• Develop and present quality point of view at governance and portfolio related meetings

• Provide Study Team Inspection Readiness (IR) guidance and support to asset teams and pivotal study teams that have a high likelihood of regulatory inspection; lead teams through pre‑submission IR deep dive and storyboards

• Develop and maintain inspection readiness tools and processes

• In conjunction with IMQA, coordinate business line GCP inspection support activities including but not limited to requests for dossiers, pre‑inspection requests, during inspections and through the development of written responses to findings.

• GCP quality representative of the PRD due diligence team for business development opportunities.

• GCP quality representative on integration teams responsible for the identification of key quality risks and proposed mitigations and incorporate into study level risk planning.

• Provide strategic input to risk‑based quality approaches

• Where appropriate, perform Quality Integration activities including but not limited to: representing quality functional lines at integration workshops or operational workshops, facilitating GCP Quality Integration Work streams, and developing quality project plans for GCP business deal activities (e.g., integration operations)

• Develop and present quality related information at relevant governance and/or operational meetings

• Advise asset/study team on appropriate escalation pathways for quality concerns

• Communicate key quality information (e.g. inspection/audit learnings) across asset/study and serve as asset quality expert

• Lead asset level/study level quality risk planning activities

A scientific or technical degree is preferred. In general, candidates for this job would have the following levels of experience:

• BS: 10+ years or equivalent

• MS/MBA: 7+ years or equivalent

• Ability to build strong network/knowledge/relationships with internal/external stakeholders

• Strong, advanced knowledge, experience and expertise in ICH GCP, clinical trial development, and operational GCP quality management disciplines such as, quality and compliance assessments, quality assurance, CAPA management, deviation management, root cause analysis, audit and regulatory inspection process, and/or inspection readiness.

• Familiarity with the relevant key…